Lyell Immunopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. 

CEO
Lynn Seely
CEOLynn Seely
Employees
161
Employees161
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
161
Employees161

LYEL Key Statistics

Market cap
342.83M
Market cap342.83M
Price-Earnings ratio
-1.19
Price-Earnings ratio-1.19
Dividend yield
Dividend yield
Average volume
186.24K
Average volume186.24K
High today
$14.02
High today$14.02
Low today
$13.42
Low today$13.42
Open price
$13.77
Open price$13.77
Volume
106.06K
Volume106.06K
52 Week high
$45.00
52 Week high$45.00
52 Week low
$10.49
52 Week low$10.49

Stock Snapshot

Lyell Immunopharma(LYEL) stock is priced at $13.95, giving the company a market capitalization of 342.83M. It carries a P/E multiple of -1.19.

During the trading session on 2026-08-14, Lyell Immunopharma(LYEL) shares reached a daily high of $14.02 and a low of $13.42. At a current price of $13.95, the stock is +3.9% higher than the low and still -0.5% under the high.

Trading volume for Lyell Immunopharma(LYEL) stock has reached 106.06K, versus its average volume of 186.24K.

Over the past 52 weeks, Lyell Immunopharma(LYEL) stock has traded between a high of $45.00 and a low of $10.49.

Over the past 52 weeks, Lyell Immunopharma(LYEL) stock has traded between a high of $45.00 and a low of $10.49.

LYEL News

Investing.com 3d
Lyell Immunopharma VP Bulis sells $8,905 of common stock - Investing.com

...

Lyell Immunopharma VP Bulis sells $8,905 of common stock - Investing.com
Simply Wall St 7d
Possible Signal As Lyell Immunopharma Insiders Sell US$527k In Stock

Last week, Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) stock jumped 14%, but insiders who sold US$527k worth of stock in over the past year are likely to be in a b...

Possible Signal As Lyell Immunopharma Insiders Sell US$527k In Stock

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
0%
Sell
12.5%

People also own

Based on the portfolios of people who own LYEL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.